MolecuLight^®'s innovative solution:
Best Practices & Health Equity

Looking for practical guidance on when to use MolecuLight^®?

32 wound care experts joined forces to establish best practices on bacterial fluorescence imaging. Recommendations cover imaging workflow, patient selection criteria, and when and how often to use this technology.

MolecuLight^® supports wound care equity by improving bacterial detection for all patients with any skin color.

This 350-patient clinical study validates the diagnostic accuracy of MolecuLight^® on all skin tones and reveals the inherent bias of standard assessment that underserves patients of color.

MolecuLight is presented as a vital tool for equitable wound care, enhancing clinical decisions, improving healing, and reducing complications, especially for underserved minority populations at higher risk of poor health outcomes.

This tutorial equips clinicians with the knowledge to identify MolecuLight fluorescence signals in wounds, using clinical examples to aid in image interpretation. It focuses on image artifacts, potential confounders, and strategies for overcoming challenges in wound imaging.

This study validated fluorescence imaging for detecting bacterial burden in diverse wound types, extending its application to an Asian population for the first time.